Cholesterol, omega-3 fatty acids, and suicide risk: Empirical evidence and pathophysiological hypotheses;Cholesterin, omega-3-fettsäuren und suizidrisiko: Empirische evidenz und pathophysiologische hypothesen

Fortschritte der Neurologie Psychiatrie

Volumn 69, Issue 10, 2001, Pages 460-467

  Brunner, J ^a   Parhofer, K G ^b   Schwandt, P ^b   Bronisch, T ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; MEVINOLIN; OMEGA 3 FATTY ACID; PRAVASTATIN; SIMVASTATIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DEPRESSION; DIET; HUMAN; LIFE EVENT; MALNUTRITION; PATHOPHYSIOLOGY; RISK FACTOR; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR; SUICIDE; WEIGHT REDUCTION;

CHOLESTEROL; DIET; FATTY ACIDS, OMEGA-3; HUMANS; PSYCHOPATHOLOGY; RISK ASSESSMENT; RISK FACTORS; SUICIDE;

EID: 0034777480     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17564     Document Type: Article

References (75)

1. The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol
2. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: Relationship with immune-inflammatory markers
3. Low serum cholesterol in suicide attempters
4. Imipramine treatment and increased serum cholesterol levels
5. Carbamazepine-induced increases in total serum cholesterol: Clinical and theoretical implications
6. The impact of clozapine treatment on serum lipids in chronic schizophrenic patients
7. Plasma cholesterol and depressive symptoms in older men
8. Depressive symptoms, social support, and lipid profile in healthy middle-aged women
9. The relationship between suicidality and depression
10. Neurobiologische korrelate suizidalen verhaltens
11. Serum cholesterol levels in homicidal offenders
12. Low cholesterol and violent crime
13. Plasma lipid levels and psychologic characteristics in men
14. Serum cholesterol and impulsivity in personality disorders
15. No correlation of serum cholesterol levels with measures of violence in patients with schizophrenia and non-psychotic disorders
16. The concentration of neurotransmitter matabolites in the cerebrospinal fluid of suicidal individuals: A meta-analysis
17. The neurobiology of suicide
18. Low serum cholesterol and suicide
19. Low serum cholesterol and suicide
20. Suicide: A four-pathway clinical-biochemical model
21. Effect of plasma membrane fluidity on serotonin transport by endothelial cells
22. Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes
23. Differential effect of cholesterol on two types of 5-hydroxytryptamine binding sites
24. Modulation of serotonergic receptors by exogenous cholesterol in the dog synaptosomal plasma membrane
25. 1 binding and dopamine-stimulated adenylate cyclase
26. Low serum cholesterol and suicide
27. Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys
28. Effects of a low-fat diet on brain serotonergic responsivity in cynomolgus monkeys
29. Assessing the observed relationship between low cholesterol and violence-related mortality. Implications for suicide risk
30. Low serum cholesterol concentrations and serotonin metabolism in men
31. Cholesterol and serotonin: Seeking a possible link between blood cholesterol and CSF 5-HIAA
32. Low blood cholesterol and low platelet serotonin levels in violent suicide attempters
33. Omega-3 fatty acids in psychiatry
34. Do plasma polyunsaturates predict hostility and depression?
35. Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy
36. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression
37. Fatty acid composition in major depression: Decreased ω3 fractions in cholesteryl esters and increased C20: 4ω3/C20:5ω3 ratio in cholesteryl esters and phospholipids
38. Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients
39. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
40. Omega 3 fatty acids in bipolar disorder. A preliminary double-blind, placebo-controlled trial
41. Chronic dietary α-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats
42. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics
43. Plasma phospholipid essential fatty acids and prostaglandins in alcoholic, habitually violent, and impulsive offenders
44. The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study
45. A replication study of violent and nonviolent subjects: Cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids
46. Serum cholesterol concentrations and mortality from accidents, suicide, and other violent causes
47. Serum cholesterol concentration and death from suicide in men: Paris prospective study I
48. Association of low serum total cholesterol with major depression and suicide
49. Serum cholesterol level and mortality due to suicide and trauma in the Honolulu heart program
50. High serum cholesterol and risk of suicide
51. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials
52. Cholesterol lowering and morbidity and mortality
53. Vermehrte autoaggressivität durch cholesterinsenkende medikamente?
54. Low or lowered cholesterol and risk of death from suicide and trauma
55. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
56. Depressive symptoms and cholesterol-lowering drugs
57. Depressive symptoms in hypercholesterolaemic patients treated with pravastatin
58. Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol-lowering drugs
59. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian simvastatin survival study (4S)
60. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
61. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
62. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
63. The long-term intervention with pravastatin in ischaemic disease (LIPID) study group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
64. Effects of statins on risk of coronary heart disease. A meta-analysis of randomized controlled trials
65. Associations of cholesterol lowering by statins with anger and hostility in hypercholesterolemic men
66. Autoaggressive behaviour and cholesterol
67. Serum cholesterol levels and suicidal tendencies in psychiatric inpatients
68. Total cholesterol and suicidality in depression
69. Serum cholesterol concentrations in parasuicide
70. Low serum cholesterol level and attempted suicide
71. Serum cholesterol, triglyceride and suicide in depressed patients
72. Serum cholesterol, suicidal tendencies, impulsivity, aggression, and depression in adolescent psychiatric inpatients
73. Hypocholesterolemia and affective disorders
74. Lower degree of esterification of serum cholesterol in depression: Relevance for depression and suicide research
75. Serum lipids and mood in working men and women in Sweden